BusinessCytoDyn Announces Favorable Protocol Modifications for Pivotal Phase 3 Combination Trial With PRO 140 After Positive FDA MeetingBy Nasdaq OMXOct 6, 2016, 10:30 AM UTC
BusinessKaryopharm to Present Updated SIGN Phase 2 Clinical Data at European Society of Medical Oncology 2016 Annual MeetingBy Nasdaq OMXOct 5, 2016, 10:19 AM UTC
BusinessNewLink Genetics Awarded $25 Million Contract from BARDA for Investigational Ebola Zaire Vaccine (V920)By Nasdaq OMXOct 4, 2016, 8:10 PM UTC
BusinessPositiveID Corporation Discusses Q3 Highlights including U.S. Department of Homeland Security Contract in New Interview with SmallCapVoice.comBy Nasdaq OMXOct 4, 2016, 12:00 PM UTC
BusinessCORRECTED: Crescendo Bioscience Announces Four Poster Presentations at the American College of Rheumatology 2016 Annual MeetingBy Nasdaq OMXOct 3, 2016, 8:20 PM UTC
BusinessCrescendo Bioscience Announces Four Poster Presentations at the American College of Rheumatology 2016 Annual MeetingBy Nasdaq OMXOct 3, 2016, 11:05 AM UTC
BusinessMultiple Sutherland Healthcare Solutions Delivery Sites Receive Prestigious URAC Accreditation, Highlighting Commitment to Quality and ServiceBy Nasdaq OMXOct 3, 2016, 11:00 AM UTC
